Metabiomed and Korea Institute of Machinery and Materials to Develop ‘Polymer Filler-Based Aesthetic Devices’

Metabiomed, a high-performance biomedical materials specialist, announced on June 18 that it has signed a memorandum of understanding (MOU) and an outsourced research contract with the Korea Institute of Machinery and Materials for the joint development of aesthetic medical devices.

View original image

Metabiomed has recently been expanding its business into the aesthetic medical device sector. As part of this initiative, the two organizations plan to combine the advanced “high-pressure, high-speed injection technology” of the Carbon Neutral Machinery Research Institute at the Korea Institute of Machinery and Materials with Metabiomed’s global biomedical expertise.

The core focus of the joint development is to establish a high-value-added business model that organically integrates equipment and biomaterials. Metabiomed plans to link the jointly developed aesthetic medical device with its flagship lineup of polymer fillers, including PDO and PDLLA product groups.

Through this strategy, the company aims to enhance product competitiveness and build an integrated portfolio that combines medical devices and consumables (biomaterials), thereby maximizing both sales volume and profitability in the global aesthetic medical market.

Jisoo Oh, CEO of Metabiomed, stated, “Through this collaboration with the Korea Institute of Machinery and Materials, we have secured unique proprietary technology and will be able to accelerate commercialization. We will further advance our technology and pursue global certifications without delay so that we can successfully launch our products in 2027 and lead the next-generation medical and aesthetic markets.”

Established in 1990, Metabiomed is a medical device company specializing in biodegradable sutures and dental materials. Recently, the company has been expanding its portfolio of medical beauty products—including lifting threads, skin boosters, and fillers—based on proprietary biopolymer technology.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.